Stock SMMT SUMMIT THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Summit Therapeutics Inc.

Equities

SMMT

US86627T1088

Real-time Estimate Cboe BZX
Other stock markets
 03:26:16 2024-07-11 pm EDT 		5-day change 1st Jan Change
8.625 USD +4.04% Intraday chart for Summit Therapeutics Inc. +18.92% +229.89%
Jul. 01 Summit Therapeutics Inc.(NasdaqGM:SMMT) added to Russell Small Cap Comp Value Index CI
Jul. 01 Summit Therapeutics Inc.(NasdaqGM:SMMT) dropped from Russell Microcap Growth Index CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)
AQ
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
Summit Therapeutics Inc.(NasdaqGM:SMMT) added to Russell Small Cap Comp Value Index
CI
Summit Therapeutics Inc.(NasdaqGM:SMMT) dropped from Russell Microcap Growth Index
CI
Summit Therapeutics Inc.(NasdaqGM:SMMT) added to Russell 3000 Value Index
CI
Summit Therapeutics Inc.(NasdaqGM:SMMT) dropped from Russell Microcap Index
CI
Summit Therapeutics Inc.(NasdaqGM:SMMT) added to Russell 2500 Value Index
CI
Summit Therapeutics Inc.(NasdaqGM:SMMT) added to Russell 2000 Value Index
CI
Summit Therapeutics Inc.(NasdaqGM:SMMT) dropped from Russell 3000E Growth Index
CI
Summit Therapeutics Inc.(NasdaqGM:SMMT) added to Russell 3000E Value Index
CI
Summit Therapeutics Inc.(NasdaqGM:SMMT) dropped from Russell 3000E Index
CI
Summit Therapeutics Inc. Enters into Two Sublease Agreements with Genius 24C Inc. and Duggan Investments Research LLC
CI
Summit Therapeutics Appoints Jeff Huber, Transformational Google and GRAIL Executive, to its Board of Directors
BU
Summit Therapeutics Inc. Appoints Jeff Huber to Its Board of Directors
CI
Akebia Therapeutics, Inc. Appoints Erik Ostrowski as Senior Vice President and Chief Business Officer
CI
Akebia Therapeutics, Inc. Appoints Erik Ostrowski as Chief Financial Officer
CI
Summit Therapeutics Inc. announced that it has received $199.999998 million in funding from Baker Bros. Advisors LP
CI
Summit Therapeutics Inc. Announces Resignation of Ujwala Mahatme as Member of its Board
CI
Sector Update: Health Care Stocks Steady Premarket Monday
MT
Stifel Adjusts Summit Therapeutics Price Target to $14 From $8, Maintains Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SMMT Stock
  4. News Summit Therapeutics Inc.